Literature DB >> 1347953

Effects of bupropion on core body temperature of mice.

M R Zarrindast1, F Abolfathi-Araghi.   

Abstract

The effects of bupropion on core body temperature of intact or reserpinized mice were studied. Intraperitoneal (IP) administration of bupropion to mice induced a dose-dependent hypothermia. The response of bupropion was decreased by the D-2 antagonist sulpiride or pimozide, but not by the D-1 antagonist SCH 23390, antimuscarinic drug atropine, alpha-adrenergic blocker phenoxybenzimine, beta-adrenergic antagonist propranolol or antiserotonergic methergoline. Reserpine induced hypothermia, which was reversed by bupropion administration. The reversal response of bupropion was reduced by propranolol, but not sulpiride, SCH 23390, phenoxybenzamine, atropine or methergoline. It is concluded that bupropion-induced hypothermia may be mediated through D-2 receptor activation, while the reversal of reserpine-induced hypothermia by bupropion may be exerted through beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347953     DOI: 10.1007/bf02801980

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain.

Authors:  M M Sellinger-Barnette; J Mendels; A Frazer
Journal:  Neuropharmacology       Date:  1980-05       Impact factor: 5.250

3.  Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

Authors:  F E Soroko; N B Mehta; R A Maxwell; R M Ferris; D H Schroeder
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

4.  SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.

Authors:  E Carboni; R Longoni; S Deidda; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

5.  Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice.

Authors:  R F Butz; R M Welch; J W Findlay
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

Review 6.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

7.  Down regulation of beta-receptors by bupropion and its major metabolite in mouse brain.

Authors:  A S Perumal; T M Smith; R F Suckow; T B Cooper
Journal:  Neuropharmacology       Date:  1986-12       Impact factor: 5.250

8.  Reserpine-induced hypothermia: participation of beta 1 and beta 2 adrenergic receptors.

Authors:  H Francès; P Simon
Journal:  Pharmacol Biochem Behav       Date:  1987-05       Impact factor: 3.533

9.  Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia.

Authors:  O Colboc; P Protais; J Costentin
Journal:  Neurosci Lett       Date:  1983-08-29       Impact factor: 3.046

10.  Anorectic and behavioural effects of bupropion.

Authors:  M R Zarrindast; T Hosseini-Nia
Journal:  Gen Pharmacol       Date:  1988
View more
  2 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Authors:  K Freitas; S S Negus; F I Carroll; M I Damaj
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.